BioSpace News Archive

Hematopoietic stem cells are present in the bone marrow and blood. They are also known as hematopoietic progenitor cells.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global infrared thermometer market is expected to rise at an impressive rate owing to the surge in COVID-19 cases across the globe.

The acute repetitive seizure is a condition that occurs in patients with drug-refractory epilepsy. It is also known as cluster seizure, seizure flurry, breakthrough seizure, seizure cluster, serial seizure, or prolonged seizure.

iOnctura SA, a clinical stage oncology company targeting core resistance and relapse mechanisms at the tumor-stroma-immune interface, announces the support of Innosuisse in a 2-year innovation project to explore the potential of iOnctura’s lead molecule, the PI3Kδ-inhibitor IOA-244, in the treatment of lymphoma.

MicroPort Scientific Corporation announced that MicroPort Cardiac Rhythm Management Limited, which is MicroPort®'s subsidiary focused on developing and commercializing implantable pacemaker and defibrillator devices and related technologies to manage cardiac rhythm disorders, has entered into definitive agreements in connection with its Series C financing with total investment proceeds of US$150 million.

Samsung Biologics, the world’s leading contract development and manufacturing organization, announced strong financial results for the second quarter of fiscal 2021.

Prokarium, a biopharmaceutical company pioneering the oncology field of microbial immunotherapy, announced the appointment of Kristen Albright, PharmD, as Chief Executive Officer.

Centene Corporation announced its financial results for the second quarter ended June 30, 2021, reporting diluted loss per share of $ and adjusted diluted earnings per share of $1.25.

BrainStorm Cell Therapeutics Inc., a leading developer of cellular therapies for neurodegenerative diseases, announced that is has received Good Manufacturing Practice approval from the Israel Ministry of Health for three state-of-the-art cleanrooms leased by the Company at the Tel Aviv Sourasky Medical Center in Tel Aviv, Israel.

Biodesix, Inc., a leading data-driven diagnostic solutions company with a focus in lung disease, announced that it will release financial results for the second quarter ended June 30, 2021 after the close of trading on Tuesday, August 10.